{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:50:41Z","timestamp":1791330641090,"version":"4.3.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epigenetic regulation and gene transcription are dynamically modulated by extracellular signals, including focal adhesions; however, the role of integrins in these processes remains poorly understood. In this study in HPV-negative head and neck squamous cell carcinoma, (HNSCC), we combined investigations in physiological three-dimensional, matrix-embedded cell models and patient-derived organoids with multi-omics analyses, bioinformatics and artificial intelligence, to unmask the integrin effector signaling network that reshapes chromatin to drive cancer. Among the 12 \u03b1\/\u03b21 integrin receptors, \u03b17 integrin (ITGA7) emerged as the most potent modulator of histone post-translational modifications, associated with significant changes in gene transcription and chromatin accessibility. Depletion of ITGA7, achieved independently by CRISPR\/Cas9 knockout and RNA interference, reduced chromatin accessibility at the AURKA locus and downregulated an AURKA-centered transcriptional program. Mechanistically, phosphoproteomics revealed significant inhibition of MAPK- and PI3K\/AKT-dependent signaling with concomitant functional impairment of cell cycling and cell survival upon ITGA7 depletion. Across all analyses, machine-learning-based feature selection consistently nominated AURKA as the dominant downstream node, and tumor ITGA7 expression stratified patient overall survival in a non-linear manner. In summary, these findings establish \u03b17 integrin as a key co-regulator of chromatin accessibility and gene transcription in HPV-negative HNSCC, acting through an AURKA-centered axis that couples adhesion signaling to cell cycle control and patient survival, and nominate AURKA, potentially targetable with clinical Aurora-A inhibitors such as alisertib, as an actionable therapeutic node downstream of the currently non-druggable ITGA7.<\/jats:p>","DOI":"10.1038\/s41392-026-02995-9","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:01:49Z","timestamp":1791327709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b17 integrin co-regulates chromatin accessibility and gene expression in HPV-negative head and neck cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-3706","authenticated-orcid":false,"given":"Olegs","family":"Borodins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-0547","authenticated-orcid":false,"given":"Anne","family":"Vehlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sameith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Spangle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6456-5508","authenticated-orcid":false,"given":"Cornelia","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-8799","authenticated-orcid":false,"given":"Outi","family":"Monni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Mircetic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2995_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0955-0674(91)90075-A","volume":"3","author":"M Karin","year":"1991","unstructured":"Karin, M. Signal transduction and gene control. Curr. Opin. Cell Biol. 3, 467\u2013473 (1991).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2995_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller, M. et al. The epigenetic hallmarks of cancer. Cancer Discov. 14, 1783\u20131809 (2024).","journal-title":"Cancer Discov."},{"key":"2995_CR3","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton, C. et al. Embracing cancer complexity: hallmarks of systemic disease. Cell 187, 1589\u20131616 (2024).","journal-title":"Cell"},{"key":"2995_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"M-Z Jin","year":"2020","unstructured":"Jin, M.-Z. & Jin, W.-L. The updated landscape of tumor microenvironment and drug repurposing. Signal. Transduct. Target Ther. 5, 166 (2020).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2995_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"2995_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbcan.2017.03.002","volume":"1868","author":"JM Spangle","year":"2017","unstructured":"Spangle, J. M., Roberts, T. M. & Zhao, J. J. The emerging role of PI3K\/AKT-mediated epigenetic regulation in cancer. Biochim. Biophys. Acta Rev. Cancer 1868, 123\u2013131 (2017).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2995_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2995_CR8","doi-asserted-by":"publisher","unstructured":"Chastney, M. R., Kaivola, J., Lepp\u00e4nen, V.-M. & Ivaska, J. The role and regulation of integrins in cell migration and invasion. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-024-00777-1 (2024).","DOI":"10.1038\/s41580-024-00777-1"},{"key":"2995_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2995_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.matbio.2024.04.003","volume":"130","author":"SM Haake","year":"2024","unstructured":"Haake, S. M., Rios, B. L., Pozzi, A. & Zent, R. Integrating integrins with the hallmarks of cancer. Matrix Biol. 130, 20\u201335 (2024).","journal-title":"Matrix Biol."},{"key":"2995_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","volume":"31","author":"I Eke","year":"2015","unstructured":"Eke, I. & Cordes, N. Focal adhesion signaling and therapy resistance in cancer. Semin. Cancer Biol. 31, 65\u201375 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"2995_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41556-018-0234-9","volume":"21","author":"Z Sun","year":"2019","unstructured":"Sun, Z., Costell, M. & F\u00e4ssler, R. Integrin activation by talin, kindlin and mechanical forces. Nat. Cell Biol. 21, 25\u201331 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2995_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35, 347\u2013367 (2019).","journal-title":"Cancer Cell"},{"key":"2995_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1172\/JCI61350","volume":"122","author":"I Eke","year":"2012","unstructured":"Eke, I. et al. \u03b2\u2081 Integrin\/FAK\/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J. Clin. Investig. 122, 1529\u20131540 (2012).","journal-title":"J. Clin. Investig."},{"key":"2995_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/onc.2015.212","volume":"35","author":"E Dickreuter","year":"2016","unstructured":"Dickreuter, E. et al. Targeting of \u03b21 integrins impairs DNA repair for radiosensitization of head and neck cancer cells. Oncogene 35, 1353\u20131362 (2016).","journal-title":"Oncogene"},{"key":"2995_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01954-8","volume":"23","author":"F Broghammer","year":"2024","unstructured":"Broghammer, F. et al. Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome. Mol. Cancer 23, 39 (2024).","journal-title":"Mol. Cancer"},{"key":"2995_CR17","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1158\/0008-5472.CAN-15-0988","volume":"75","author":"A Franovic","year":"2015","unstructured":"Franovic, A. et al. Glioblastomas require integrin \u03b1v\u03b23\/PAK4 signaling to escape senescence. Cancer Res. 75, 4466\u20134473 (2015).","journal-title":"Cancer Res."},{"key":"2995_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17501911.2024.2388018","volume":"16","author":"Z Tang","year":"2024","unstructured":"Tang, Z. et al. LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6\/JAK1\/STAT3 signaling. Epigenomics 16, 1133\u20131148 (2024).","journal-title":"Epigenomics"},{"key":"2995_CR19","doi-asserted-by":"publisher","first-page":"27754","DOI":"10.18632\/oncotarget.10897","volume":"8","author":"M Christmann","year":"2017","unstructured":"Christmann, M. et al. Integrin \u03b1V\u03b23 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. Oncotarget 8, 27754\u201327771 (2017).","journal-title":"Oncotarget"},{"key":"2995_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11, 726\u2013734 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"2995_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"2995_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz, P. & Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703\u2013708 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2995_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"2995_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng.349","volume":"41","author":"G van Haaften","year":"2009","unstructured":"van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521\u2013523 (2009).","journal-title":"Nat. Genet."},{"key":"2995_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10555-011-9341-9","volume":"31","author":"M Deb","year":"2012","unstructured":"Deb, M., Sengupta, D. & Patra, S. K. Integrin-epigenetics: a system with imperative impact on cancer. Cancer Metastasis Rev. 31, 221\u2013234 (2012).","journal-title":"Cancer Metastasis Rev."},{"key":"2995_CR26","doi-asserted-by":"publisher","first-page":"102376","DOI":"10.1016\/j.ceb.2024.102376","volume":"88","author":"M Vivo","year":"2024","unstructured":"Vivo, M., Rosti, V., Cervone, S. & Lanzuolo, C. Chromatin plasticity in mechanotransduction. Curr. Opin. Cell Biol. 88, 102376 (2024).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2995_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303395","volume":"10","author":"S-M Park","year":"2023","unstructured":"Park, S.-M. et al. Cyclic stretch promotes cellular reprogramming process through cytoskeletal-nuclear mechano-coupling and epigenetic modification. Adv. Sci. 10, e2303395 (2023).","journal-title":"Adv. Sci."},{"key":"2995_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/35007098","volume":"404","author":"E Bianchi","year":"2000","unstructured":"Bianchi, E. et al. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404, 617\u2013621 (2000).","journal-title":"Nature"},{"key":"2995_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/hh2201.099166","volume":"89","author":"C Shi","year":"2001","unstructured":"Shi, C., Zhang, X., Chen, Z., Robinson, M. K. & Simon, D. I. Leukocyte integrin Mac-1 recruits toll\/interleukin-1 receptor superfamily signaling intermediates to modulate NF-kappaB activity. Circ. Res. 89, 859\u2013865 (2001).","journal-title":"Circ. Res."},{"key":"2995_CR30","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1158\/0008-5472.CAN-09-3848","volume":"70","author":"K Storch","year":"2010","unstructured":"Storch, K. et al. Three-dimensional cell growth confers radioresistance by chromatin density modification. Cancer Res. 70, 3925\u20133934 (2010).","journal-title":"Cancer Res."},{"key":"2995_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semradonc.2021.02.006","volume":"31","author":"PF Cosper","year":"2021","unstructured":"Cosper, P. F., Bradley, S., Luo, L. & Kimple, R. J. Biology of HPV mediated carcinogenesis and tumor progression. Semin. Radiat. Oncol. 31, 265\u2013273 (2021).","journal-title":"Semin. Radiat. Oncol."},{"key":"2995_CR32","doi-asserted-by":"publisher","first-page":"18099","DOI":"10.18632\/oncotarget.24266","volume":"9","author":"E Klapproth","year":"2018","unstructured":"Klapproth, E. et al. Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and \u03b21 integrin inhibition. Oncotarget 9, 18099\u201318114 (2018).","journal-title":"Oncotarget"},{"key":"2995_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36691-x","volume":"14","author":"J-H Choi","year":"2023","unstructured":"Choi, J.-H. et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat. Commun. 14, 1055 (2023).","journal-title":"Nat. Commun."},{"key":"2995_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin, L., Desgrosellier, J. S., Weis, S. M. & Cheresh, D. A. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 25, 234\u2013240 (2015).","journal-title":"Trends Cell Biol."},{"key":"2995_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.15252\/msb.20145216","volume":"10","author":"T Hart","year":"2014","unstructured":"Hart, T., Brown, K. R., Sircoulomb, F., Rottapel, R. & Moffat, J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 10, 733 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"2995_CR36","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1093\/nar\/gkv1166","volume":"43","author":"K Mahajan","year":"2015","unstructured":"Mahajan, K. & Mahajan, N. P. Cross talk of tyrosine kinases with the DNA damage signaling pathways. Nucleic Acids Res. 43, 10588\u201310601 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2995_CR37","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-14-2391","volume":"76","author":"NJ-M Raynal","year":"2016","unstructured":"Raynal, N. J.-M. et al. Targeting calcium signaling induces epigenetic reactivation of tumor suppressor genes in cancer. Cancer Res. 76, 1494\u20131505 (2016).","journal-title":"Cancer Res."},{"key":"2995_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41551-019-0420-5","volume":"3","author":"RS Stowers","year":"2019","unstructured":"Stowers, R. S. et al. Matrix stiffness induces a tumorigenic phenotype in mammary epithelium through changes in chromatin accessibility. Nat. Biomed. Eng. 3, 1009\u20131019 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"2995_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coisb.2017.04.005","volume":"2","author":"CR Pfeifer","year":"2017","unstructured":"Pfeifer, C. R., Alvey, C. M., Irianto, J. & Discher, D. E. Genome variation across cancers scales with tissue stiffness - an invasion-mutation mechanism and implications for immune cell infiltration. Curr. Opin. Syst. Biol. 2, 103\u2013114 (2017).","journal-title":"Curr. Opin. Syst. Biol."},{"key":"2995_CR40","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/j.yexcr.2007.04.022","volume":"313","author":"J Le Beyec","year":"2007","unstructured":"Le Beyec, J. et al. Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp. Cell Res. 313, 3066\u20133075 (2007).","journal-title":"Exp. Cell Res."},{"key":"2995_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034279","volume":"7","author":"O Zschenker","year":"2012","unstructured":"Zschenker, O., Streichert, T., Hehlgans, S. & Cordes, N. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS ONE 7, e34279 (2012).","journal-title":"PLoS ONE"},{"key":"2995_CR42","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1242\/jcs.01108","volume":"117","author":"S Dutertre","year":"2004","unstructured":"Dutertre, S. et al. Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J. Cell Sci. 117, 2523\u20132531 (2004).","journal-title":"J. Cell Sci."},{"key":"2995_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature07185","volume":"455","author":"L Mac\u016frek","year":"2008","unstructured":"Mac\u016frek, L. et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455, 119\u2013123 (2008).","journal-title":"Nature"},{"key":"2995_CR44","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1002\/j.1460-2075.1995.tb00252.x","volume":"14","author":"PJ Hurlin","year":"1995","unstructured":"Hurlin, P. J. et al. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14, 5646\u20135659 (1995).","journal-title":"EMBO J."},{"key":"2995_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jid.2022.07.020","volume":"143","author":"J Coutier","year":"2023","unstructured":"Coutier, J. et al. MXD4\/MAD4 regulates human keratinocyte precursor fate. J. Investig. Dermatol 143, 105\u2013114.e12 (2023).","journal-title":"J. Investig. Dermatol"},{"key":"2995_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2443.2006.01029.x","volume":"12","author":"K Ikegami","year":"2007","unstructured":"Ikegami, K. et al. Genome-wide and locus-specific DNA hypomethylation in G9a deficient mouse embryonic stem cells. Genes Cells 12, 1\u201311 (2007).","journal-title":"Genes Cells"},{"key":"2995_CR47","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/genes12101485","volume":"12","author":"P Flora","year":"2021","unstructured":"Flora, P., Dalal, G., Cohen, I. & Ezhkova, E. Polycomb repressive complex(es) and their role in adult stem cells. Genes 12, 1485 (2021).","journal-title":"Genes"},{"key":"2995_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22871-0","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. PHC1 maintains pluripotency by organizing genome-wide chromatin interactions of the Nanog locus. Nat. Commun. 12, 2829 (2021).","journal-title":"Nat. Commun."},{"key":"2995_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.15252\/embj.201591293","volume":"35","author":"Y Feng","year":"2016","unstructured":"Feng, Y. et al. BRPF3-HBO1 regulates replication origin activation and histone H3K14 acetylation. EMBO J. 35, 176\u2013192 (2016).","journal-title":"EMBO J."},{"key":"2995_CR50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/15384101.2019.1577525","volume":"18","author":"VR Menon","year":"2019","unstructured":"Menon, V. R. et al. DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169. Cell Cycle 18, 531\u2013551 (2019).","journal-title":"Cell Cycle"},{"key":"2995_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molcel.2014.12.026","volume":"57","author":"C Di Vona","year":"2015","unstructured":"Di Vona, C. et al. Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase. Mol. Cell 57, 506\u2013520 (2015).","journal-title":"Mol. Cell"},{"key":"2995_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41586-018-0174-3","volume":"558","author":"H Lu","year":"2018","unstructured":"Lu, H. et al. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II. Nature 558, 318\u2013323 (2018).","journal-title":"Nature"},{"key":"2995_CR53","doi-asserted-by":"publisher","first-page":"49573","DOI":"10.1074\/jbc.M307556200","volume":"278","author":"Y Zou","year":"2003","unstructured":"Zou, Y., Lim, S., Lee, K., Deng, X. & Friedman, E. Serine\/threonine kinase Mirk\/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. J. Biol. Chem. 278, 49573\u201349581 (2003).","journal-title":"J. Biol. Chem."},{"key":"2995_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.15252\/embr.201338356","volume":"15","author":"SM Jang","year":"2014","unstructured":"Jang, S. M., Azebi, S., Soubigou, G. & Muchardt, C. DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression. EMBO Rep. 15, 686\u2013694 (2014).","journal-title":"EMBO Rep."},{"key":"2995_CR55","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl, R. & Wagner, E. F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859\u2013868 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"2995_CR56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4093\/dmj.2023.0174","volume":"48","author":"H Kang","year":"2024","unstructured":"Kang, H., Park, Y.-K., Lee, J.-Y. & Bae, M. Roles of histone deacetylase 4 in the inflammatory and metabolic processes. Diab. Metab. J. 48, 340\u2013353 (2024).","journal-title":"Diab. Metab. J."},{"key":"2995_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0092-8674(02)00810-3","volume":"110","author":"X Yang","year":"2002","unstructured":"Yang, X., Zhang, F. & Kudlow, J. E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110, 69\u201380 (2002).","journal-title":"Cell"},{"key":"2995_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res 21, 381\u2013395 (2011).","journal-title":"Cell Res"},{"key":"2995_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrm3931","volume":"16","author":"E Verdin","year":"2015","unstructured":"Verdin, E. & Ott, M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat. Rev. Mol. Cell Biol. 16, 258\u2013264 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2995_CR60","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"MA Glozak","year":"2007","unstructured":"Glozak, M. A. & Seto, E. Histone deacetylases and cancer. Oncogene 26, 5420\u20135432 (2007).","journal-title":"Oncogene"},{"key":"2995_CR61","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.celrep.2017.01.055","volume":"18","author":"A Saunders","year":"2017","unstructured":"Saunders, A. et al. The SIN3A\/HDAC corepressor complex functionally cooperates with NANOG to promote pluripotency. Cell Rep. 18, 1713\u20131726 (2017).","journal-title":"Cell Rep."},{"key":"2995_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/gm419","volume":"5","author":"M Lechner","year":"2013","unstructured":"Lechner, M. et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 5, 15 (2013).","journal-title":"Genome Med."},{"key":"2995_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24\u201335 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2995_CR64","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920\u2013926 (2018).","journal-title":"Science"},{"key":"2995_CR65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407\u2013418 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2995_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.137.1.231","volume":"137","author":"VM Weaver","year":"1997","unstructured":"Weaver, V. M. et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231\u2013245 (1997).","journal-title":"J. Cell Biol."},{"key":"2995_CR67","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.cellbio.22.010305.104315","volume":"22","author":"CM Nelson","year":"2006","unstructured":"Nelson, C. M. & Bissell, M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22, 287\u2013309 (2006).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2995_CR68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1158\/0008-5472.CAN-12-2021","volume":"73","author":"I Eke","year":"2013","unstructured":"Eke, I. et al. EGFR\/JIP-4\/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Res. 73, 297\u2013306 (2013).","journal-title":"Cancer Res."},{"key":"2995_CR69","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 9, 852\u2013871 (2019).","journal-title":"Cancer Discov."},{"key":"2995_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00168-1","volume":"5","author":"GE Wensink","year":"2021","unstructured":"Wensink, G. E. et al. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. npj Precis Oncol. 5, 30 (2021).","journal-title":"npj Precis Oncol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02995-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:02:00Z","timestamp":1791327720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02995-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2995"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02995-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"HNSCC and normal tissue samples (Supplementary Table\n                      \n                      ) were obtained from the tissue bank for tumor and normal tissues of the University Cancer Center (UCC), National Center for Tumor Diseases (NCT) Dresden. Patients gave informed consent as intended by the ethics committee of the Technische Universit\u00e4t Dresden (EK 59032007). HNSCC patient-derived organoids (PDOs; Supplementary Table\n                      \n                      ) were established from fresh primary tumor biopsies obtained from HNSCC patients surgically treated at the University Hospital Dresden. The study was conducted in accordance with institutional review board guidelines and approved by the Landesdirektion Sachsen (April 16, 2025; approval no. BO-EK-241052022). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"429"}}